This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Discussing Rinvoq's label expansion for patients with giant cell arteritis.
Ticker(s): ABBVWho's the expert?
Institution: Rheumatology Specialty Center
- Board certified by the American Board of Internal Medicine and Subspecialty of Rheumatology
- Awarded the Darilyn Moyer, MD, FACP Professionalism Award in 2018
- Completed Rheumatology fellowship at Temple University Hospital, Philadelphia, PA (Cheif fellow)
- Manages 300 patients for giant cell arteritis (GCA)
Interview GoalThis conversation will focus on the treatment landscape and potential use of Rinvoq for patients with GCA.
Are You Interested In These Questions?
Slingshot Insights Explained
- Call Date
- May 15, 2025
- Call Time
- 10:30 AM EDT
Wall Street Time
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
